Moreover, earlier work has highlighted that the topography of tau-PET uptake is associated with domain-specific cognitive decline.31 More recent work has also provided evidence for tau-PET association with executive dysfunction in CU individuals.7 Thus, it should be noted that tau-PET can be used to capture cognitive decline in different domains as well. The gene discussed is MAPT; the disease is Mental deterioration.